Skip to main content
NIH funding notice RFA-DA-18-015

HIV-associated neuropathic pain and opioid interaction (R01)

Closed on December 18, 2017.

Posted
August 3, 2017
Close date
December 18, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,057,511 in first-year total cost, median $528,756.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 JXB-N (14)]2

Most frequent institutions

  1. MASSACHUSETTS GENERAL HOSPITAL1
  2. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE1
Competing awards under RFA-DA-18-015 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Imaging neuroglial mechanisms of neuropathic pain-opioid interaction in HIV1R01DA047088-01LOGGIA, MARCO LUCIANORATAI, EVA-MARIAMASSACHUSETTS GENERAL HOSPITAL, MA$592,994ZDA1
2018Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy1R01DA047089-01HAO, SHUANGLINRAMAKRISHNAN, SUNDARAMROY, SABITAUNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL$464,517ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.